The Pam and Rolando Del Maestro Family Undergraduate Student Research Competition Awards

In 2017, The Pam And Rolando Del Maestro Family Undergraduate Student Research Competition Awards were established to promote scientific innovation among Canadian undergraduate students.

35 years ago, Pam and Rolando Del Maestro co-founded Brain Tumour Foundation of Canada and over the years have fostered students in the field of brain tumour research by providing them with varied opportunities to present their ideas and engage with physicians and researchers in the field of neuro-oncology and neuroscience.

Brain Tumour Foundation of Canada thanks our co-founders Pam and Rolando Del Maestro for establishing this visionary opportunity. 
 

2019 Student Research Awards

This competition will take place in London, ON on Saturday, October 26, 2019. Students will compete for monetary prizes. Everyone is encouraged to attend to see the compeition, there is no charge to attend.

Note, Letters of Intent to compete were due by Friday August 23, 2019. Students do not need to be in London, ON in order to compete. Students from outside the city will be livestreamed in.
 

2018 Student Research Awards

Eight teams competed in London (some via live streaming), of which the top 4 presenters were invited to the Brain Tumour National Conference in Toronto in October to vie for the winning prize. 

Congratulations to winners!

Attached is the Letter Of Intent which they submitted for the original competition where eight teams competed.

#1 - $1,000: Novel Laser-Quantum Dot Imaging-Therapy for Diffuse Astrocytoma 

Hypothesis: We hypothesize that the tumour-specific accumulation of CDs will allow higher contrast imaging than traditional techniques. After MRI detection of the tumour, infrared lasers will be used for non-ionizing and site-specific drug release giving spatial and temporal control over drug delivery, providing a cheap and accurate method of treatment. The selected drugs will be able to induce cancer cell apoptosis, thus minimizing damage to non-cancerous regions of the brain.

Team Members: Deejesh Subramanian- Western University, Syed Mohammad Raza- University of Toronto 

Please read this article in the Western Gazette about their achievement.

Watch their presentation:

#2 - $750: Dissecting Brain Tumour Initiating Cell Properties in Diffuse Astrocytoma

Hypothesis: Targeting the unique differences in IDH1/2 wild-type BTICs will present novel therapeutic targets both for advanced glioma (including glioblastoma multiforme) and in preventing the progression of early-stage diffuse astrocytoma.

Team Members: Fatima Nadeem, Alexander Rodzinka, Jake Frank- University of Windsor

Please read this article in the University of Windsor Daily News about their achievement.

Watch their presentation:

#3 - $500: Intranasal Administration of Telomerase Inhibitor GRN163 as Adjuvant Therapy to Post-Surgical Resection in Diffuse Astrocytomas

Hypothesis: The administration of GRN163 by intranasal passageway would be an effective adjuvant treatment following surgical resection of a diffuse astrocytoma due to its ability to inhibit tumour growth, thus eventually increasing the progression-free survival and overall survival rate of diffuse astrocytoma patients. 

Team Members: Mariya Yordanova, Samantha Jacobson- McGill University, Amanda Walsh- Concordia University, Myriam Boucher-Pinard- Dawson College

Watch their presentation:

#3 - $500: Team 1: Novel Agents Targeting Diffuse Astrocytoma

Hypothesis: We hypothesize that cells harboring IDH1-mt status have increased tumorigenic, proliferative, self renewal and malignant transformation capacity. When used in combination with current treatment options, IDH1 inhibitors may provide a novel therapeutic modality and drive preventative treatment options for high-grade glioma transition for patients with diffuse astrocytoma. Furthermore, we hypothesize that induction of a high-grade phenotype may elucidate novel cell signalling pathways and subsequent targeting of markers in malignant transformation.

Team Members: Sabra Salim and Nikoo Aghaei- McMaster University 

Watch their presentation:

Please learn more about the qualification process and associated deadlines as outlined in this document.

From the winners of the 2017 competition:

“As an individual passionate about brain tumours, this Student Research Competition allowed me to network with like-minded students and gain a broader perspective on the multitude of novel strategies that can be employed to tackle this devastating disease. Having come first place in the competition, we were given the opportunity to present at the Join the Movement to End Brain Tumours National Conference, where we interacted with children and adults suffering or affected by brain tumours; ultimately propelling motivation and giving our work meaning. 

I encourage students interested in brain cancer research to attend and compete in this worthwhile learning opportunity!"
 

2017 Student Research Awards

The Pam And Rolando Del Maestro Family Undergraduate Student Research Competition Awards were an integral part of the Research Symposium at the Brain Tumour National Conference in October 2017. 

Congratulations to the winners!

#1: McMaster - Team Adile - $1,000 - “Novel agents targeting therapy-resistant GBM stem cells”

#2: McGill - Team An - $750 - “The combination of nanoparticles and RNAi technology to combat glioblastoma with patient specificity”

#3: Waterloo/Laurier - Team Roble - $500 - “Palliative Care Communication Strategies to Improve outcomes for Glioblastoma patients and their families”

Thanks also to the runners up:

Assessing a VR Training Curriculum for Surgical Skills Towards Safer Neurosurgery 

Presented by: Vanier - Team Khan
Presented on: Friday, October 20, 2017 

Please note: Undergraduate students wishing to compete in this competition were encouraged to apply from anywhere in Canada. If selected to compete and not able to attend in person, teams were streamed in.

To speak to someone about the Student Research Award, please contact:

Susan Ruypers
Research Program Specialist
sruypers@braintumour.ca
1-800-265-5106 ext. 240